The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Participant recruitment for medical research is challenging. Slow accrual leads to delays in research. Accrual monitoring during the process of recruitment is critical. Researchers need reliable tools to manage the accrual rate. We developed a Bayesian method that integrates the researcher's experience with previous trials and data from the current study, providing reliable predictions on accrual rate for clinical studies. For more details and background on these methodologies, see the publications of Byron, Stephen and Susan (2008) <doi:10.1002/sim.3128>, and Yu et al. (2015) <doi:10.1002/sim.6359>. In this R package, Bayesian accrual prediction functions are presented, which can be easily used by statisticians and clinical researchers.
| Version: | 1.4 |
| Depends: | R (≥ 3.1.3), tcltk2 |
| Imports: | fgui, SMPracticals |
| Published: | 2023-11-26 |
| DOI: | 10.32614/CRAN.package.accrual |
| Author: | Junhao Liu [aut, cre] (Maintainer), Yu Jiang [aut] (Original author), Cen Wu [aut], Steve Simon [aut], Matthew S. Mayo [aut], Rama Raghavan [aut], Byron J. Gajewski [aut] |
| Maintainer: | Junhao Liu <liujunhao2008 at gmail.com> |
| License: | GPL-2 |
| NeedsCompilation: | no |
| CRAN checks: | accrual results |
| Reference manual: | accrual.pdf |
| Package source: | accrual_1.4.tar.gz |
| Windows binaries: | r-devel: accrual_1.4.zip, r-release: accrual_1.4.zip, r-oldrel: accrual_1.4.zip |
| macOS binaries: | r-release (arm64): accrual_1.4.tgz, r-oldrel (arm64): accrual_1.4.tgz, r-release (x86_64): accrual_1.4.tgz, r-oldrel (x86_64): accrual_1.4.tgz |
| Old sources: | accrual archive |
Please use the canonical form https://CRAN.R-project.org/package=accrual to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.